Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000221687 | SCV000269976 | likely benign | not specified | 2015-01-28 | criteria provided, single submitter | clinical testing | p.Pro258Pro in exon 4 of ACTG1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 65/65542 European ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs61997068). |
Labcorp Genetics |
RCV001078583 | SCV001015831 | benign | Autosomal dominant nonsyndromic hearing loss 20; Baraitser-winter syndrome 2 | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000873773 | SCV001142906 | benign | not provided | 2018-12-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000873773 | SCV001843755 | benign | not provided | 2019-10-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253301 | SCV002524451 | benign | Baraitser-winter syndrome 2 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253300 | SCV002524452 | benign | Autosomal dominant nonsyndromic hearing loss 20 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000873773 | SCV004144608 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | ACTG1: BP4, BP7, BS1 |